Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Oncology
Join Editorial Board Propose a Special Issue
Print ISSN: 1019-6439 Online ISSN: 1791-2423
Journal Cover
March-2018 Volume 52 Issue 3

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March-2018 Volume 52 Issue 3

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Reduced-gliotoxin induces ROS-mediated anoikis in human colorectal cancer cells

  • Authors:
    • Junxiong Chen
    • Qiong Lou
    • Lu He
    • Chuangyu Wen
    • Mengmeng Lin
    • Zefeng Zhu
    • Fang Wang
    • Lanlan Huang
    • Wenjian Lan
    • Aikichi Iwamoto
    • Xiangling Yang
    • Huanliang Liu
  • View Affiliations / Copyright

    Affiliations: Guangdong Institute of Gastroenterology and the Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510655, P.R. China, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, Guangdong 510006, P.R. China, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan
  • Pages: 1023-1032
    |
    Published online on: February 1, 2018
       https://doi.org/10.3892/ijo.2018.4264
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Reduced-gliotoxin is a small molecule derived from the secondary metabolites of marine fungi; compared to other gliotoxin analogues, it exhibits potent anticancer effects. However, the molecular basis of the death of colorectal cancer (CRC) cells induced by reduced-gliotoxin is unclear. Thus, the aim of this study was to investigate the potency of reduced-gliotoxin against CRC cells and to elucidate the underlying mechanisms. Cell morphology, flow cytometric analysis and western bolt analysis were performed to examine the functions and mechanisms of cell death induced by reduced-gliotoxin. Our findings demonstrated that reduced-gliotoxin triggered rapid cell detachment and induced anoikis in CRC cells. Mechanistically, our data indicated that the anoikis induced by reduced-gliotoxin was associated with the disruption of integrin-associated cell detachment and multiple signaling pathways. Furthermore, reduced-gliotoxin induced the excessive production of reactive oxygen species (ROS) and the disruption of mitochondrial membrane potential (MMP), resulting in the activation of both endogenous and exogenous apoptotic pathways and eventually, in the apoptosis of CRC cells. The blockage of ROS generation with N-acetylcysteine (NAC) attenuated the anoikis induced by reduced-gliotoxin. Taken together, these results suggest that reduced-gliotoxin may prove to be a potential candidate in the treatment of CRC.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Siegel RL, Miller KD and Jemal A: Cancer statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI

2 

Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China, 2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI

3 

Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics, 2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI

4 

März L and Piso P: Treatment of peritoneal metastases from colorectal cancer. Gastroenterol Rep (Oxf). 3:298–302. 2015.

5 

Gilmore AP: Anoikis. Cell Death Differ. 12(Suppl 2): 1473–1477. 2005. View Article : Google Scholar : PubMed/NCBI

6 

Chiarugi P and Giannoni E: Anoikis: A necessary death program for anchorage-dependent cells. Biochem Pharmacol. 76:1352–1364. 2008. View Article : Google Scholar : PubMed/NCBI

7 

Grossmann J: Molecular mechanisms of 'detachment-induced apoptosis - Anoikis'. Apoptosis. 7:247–260. 2002. View Article : Google Scholar : PubMed/NCBI

8 

Simpson CD, Anyiwe K and Schimmer AD: Anoikis resistance and tumor metastasis. Cancer Lett. 272:177–185. 2008. View Article : Google Scholar : PubMed/NCBI

9 

Nagaprashantha LD, Vatsyayan R, Lelsani PC, Awasthi S and Singhal SS: The sensors and regulators of cell-matrix surveillance in anoikis resistance of tumors. Int J Cancer. 128:743–752. 2011. View Article : Google Scholar

10 

Shanmugathasan M and Jothy S: Apoptosis, anoikis and their relevance to the pathobiology of colon cancer. Pathol Int. 50:273–279. 2000. View Article : Google Scholar : PubMed/NCBI

11 

Frisch SM and Screaton RA: Anoikis mechanisms. Curr Opin Cell Biol. 13:555–562. 2001. View Article : Google Scholar : PubMed/NCBI

12 

Cragg GM and Newman DJ: Natural products: A continuing source of novel drug leads. Biochim Biophys Acta. 1830:3670–3695. 2013. View Article : Google Scholar : PubMed/NCBI

13 

Saleem M, Ali MS, Hussain S, Jabbar A, Ashraf M and Lee YS: Marine natural products of fungal origin. Nat Prod Rep. 24:1142–1152. 2007. View Article : Google Scholar : PubMed/NCBI

14 

Liang WL, Le X, Li HJ, Yang XL, Chen JX, Xu J, Liu HL, Wang LY, Wang KT, Hu KC, et al: Exploring the chemodiversity and biological activities of the secondary metabolites from the marine fungus Neosartorya pseudofischeri. Mar Drugs. 12:5657–5676. 2014. View Article : Google Scholar : PubMed/NCBI

15 

Bugni TS and Ireland CM: Marine-derived fungi: A chemically and biologically diverse group of microorganisms. Nat Prod Rep. 21:143–163. 2004. View Article : Google Scholar : PubMed/NCBI

16 

Lan WJ, Fu SJ, Xu MY, Liang WL, Lam CK, Zhong GH, Xu J, Yang DP and Li HJ: Five new cytotoxic metabolites from the marine fungus Neosartorya pseudofischeri. Mar Drugs. 14:182016. View Article : Google Scholar : PubMed/NCBI

17 

Yan DF, Lan WJ, Wang KT, Huang L, Jiang CW and Li HJ: Two chlorinated benzofuran derivatives from the marine fungus Pseudallescheria boydii. Nat Prod Commun. 10:621–622. 2015.PubMed/NCBI

18 

Yamada A, Kataoka T and Nagai K: The fungal metabolite gliotoxin: Immunosuppressive activity on CTL-mediated cytotoxicity. Immunol Lett. 71:27–32. 2000. View Article : Google Scholar : PubMed/NCBI

19 

Sun Y, Takada K, Takemoto Y, Yoshida M, Nogi Y, Okada S and Matsunaga S: Gliotoxin analogues from a marine-derived fungus, Penicillium sp., and their cytotoxic and histone methyltransferase inhibitory activities. J Nat Prod. 75:111–114. 2012. View Article : Google Scholar

20 

Chen J, Wang C, Lan W, Huang C, Lin M, Wang Z, Liang W, Iwamoto A, Yang X and Liu H: Gliotoxin inhibits proliferation and induces apoptosis in colorectal cancer cells. Mar Drugs. 13:6259–6273. 2015. View Article : Google Scholar : PubMed/NCBI

21 

Nguyen VT, Lee JS, Qian ZJ, Li YX, Kim KN, Heo SJ, Jeon YJ, Park WS, Choi IW, Je JY, et al: Gliotoxin isolated from marine fungus Aspergillus sp induces apoptosis of human cervical cancer and chondrosarcoma cells. Mar Drugs. 12:69–87. 2013. View Article : Google Scholar : PubMed/NCBI

22 

Hubmann R, Hilgarth M, Schnabl S, Ponath E, Reiter M, Demirtas D, Sieghart W, Valent P, Zielinski C, Jäger U, et al: Gliotoxin is a potent NOTCH2 transactivation inhibitor and efficiently induces apoptosis in chronic lymphocytic leukaemia (CLL) cells. Br J Haematol. 160:618–629. 2013. View Article : Google Scholar : PubMed/NCBI

23 

Pan XQ and Harday J: Electromicroscopic observations on gliotoxin-induced apoptosis of cancer cells in culture and human cancer xenografts in transplanted SCID mice. In Vivo. 21:259–265. 2007.PubMed/NCBI

24 

Burnette WN: 'Western blotting': Electrophoretic transfer of proteins from sodium dodecyl sulfate - polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem. 112:195–203. 1981. View Article : Google Scholar : PubMed/NCBI

25 

Geissler A, Haun F, Frank DO, Wieland K, Simon MM, Idzko M, Davis RJ, Maurer U and Borner C: Apoptosis induced by the fungal pathogen gliotoxin requires a triple phosphorylation of Bim by JNK. Cell Death Differ. 20:1317–1329. 2013. View Article : Google Scholar : PubMed/NCBI

26 

Maamer-Azzabi A, Ndozangue-Touriguine O and Bréard J: Metastatic SW620 colon cancer cells are primed for death when detached and can be sensitized to anoikis by the BH3-mimetic ABT-737. Cell Death Dis. 4:e8012013. View Article : Google Scholar : PubMed/NCBI

27 

Fulda S and Debatin KM: Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene. 25:4798–4811. 2006. View Article : Google Scholar : PubMed/NCBI

28 

Ata R and Antonescu CN: Integrins and cell metabolism: An intimate relationship impacting cancer. Int J Mol Sci. 18:182017. View Article : Google Scholar

29 

Alanko J, Mai A, Jacquemet G, Schauer K, Kaukonen R, Saari M, Goud B and Ivaska J: Integrin endosomal signalling suppresses anoikis. Nat Cell Biol. 17:1412–1421. 2015. View Article : Google Scholar : PubMed/NCBI

30 

Yoo BH, Masson O, Li Y, Khan IA, Gowda PS and Rosen KV: Anoikis of colon carcinoma cells triggered by β-catenin loss can be enhanced by tumor necrosis factor receptor 1 antagonists. Oncogene. 34:4939–4951. 2015. View Article : Google Scholar

31 

Paoli P, Giannoni E and Chiarugi P: Anoikis molecular pathways and its role in cancer progression. Biochim Biophys Acta. 1833:3481–3498. 2013. View Article : Google Scholar : PubMed/NCBI

32 

Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y, Zhang Z, Lin X and He X: Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell. 108:837–847. 2002. View Article : Google Scholar : PubMed/NCBI

33 

Luo J: Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy. Cancer Lett. 273:194–200. 2009. View Article : Google Scholar

34 

Pardo J, Urban C, Galvez EM, Ekert PG, Müller U, Kwon-Chung J, Lobigs M, Müllbacher A, Wallich R, Borner C, et al: The mitochondrial protein Bak is pivotal for gliotoxin-induced apoptosis and a critical host factor of Aspergillus fumigatus virulence in mice. J Cell Biol. 174:509–519. 2006. View Article : Google Scholar : PubMed/NCBI

35 

Kweon YO, Paik YH, Schnabl B, Qian T, Lemasters JJ and Brenner DA: Gliotoxin-mediated apoptosis of activated human hepatic stellate cells. J Hepatol. 39:38–46. 2003. View Article : Google Scholar : PubMed/NCBI

36 

Suen YK, Fung KP, Lee CY and Kong SK: Gliotoxin induces apoptosis in cultured macrophages via production of reactive oxygen species and cytochrome c release without mitochondrial depolarization. Free Radic Res. 35:1–10. 2001. View Article : Google Scholar : PubMed/NCBI

37 

Ruoslahti E and Reed JC: Anchorage dependence, integrins, and apoptosis. Cell. 77:477–478. 1994. View Article : Google Scholar : PubMed/NCBI

38 

Beaulieu JF: Integrin α6β4 in colorectal cancer. World J Gastrointest Pathophysiol. 1:3–11. 2010. View Article : Google Scholar

39 

Scartozzi M, Giampieri R, Loretelli C, Mandolesi A, del Prete M, Biagetti S, Alfonsi S, Faloppi L, Bianconi M, Bittoni A, et al: Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab. Future Oncol. 9:1207–1214. 2013. View Article : Google Scholar : PubMed/NCBI

40 

Fujita S, Watanabe M, Kubota T, Teramoto T and Kitajima M: Alteration of expression in integrin beta 1-subunit correlates with invasion and metastasis in colorectal cancer. Cancer Lett. 91:145–149. 1995. View Article : Google Scholar : PubMed/NCBI

41 

Pelillo C, Mollica H, Eble JA, Grosche J, Herzog L, Codan B, Sava G and Bergamo A: Inhibition of adhesion, migration and of α5β1 integrin in the HCT-116 colorectal cancer cells treated with the ruthenium drug NAMI-A. J Inorg Biochem. 160:225–235. 2016. View Article : Google Scholar : PubMed/NCBI

42 

Scharf DH, Brakhage AA and Mukherjee PK: Gliotoxin - bane or boon? Environ Microbiol. 18:1096–1109. 2016. View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Chen J, Lou Q, He L, Wen C, Lin M, Zhu Z, Wang F, Huang L, Lan W, Iwamoto A, Iwamoto A, et al: Reduced-gliotoxin induces ROS-mediated anoikis in human colorectal cancer cells. Int J Oncol 52: 1023-1032, 2018.
APA
Chen, J., Lou, Q., He, L., Wen, C., Lin, M., Zhu, Z. ... Liu, H. (2018). Reduced-gliotoxin induces ROS-mediated anoikis in human colorectal cancer cells. International Journal of Oncology, 52, 1023-1032. https://doi.org/10.3892/ijo.2018.4264
MLA
Chen, J., Lou, Q., He, L., Wen, C., Lin, M., Zhu, Z., Wang, F., Huang, L., Lan, W., Iwamoto, A., Yang, X., Liu, H."Reduced-gliotoxin induces ROS-mediated anoikis in human colorectal cancer cells". International Journal of Oncology 52.3 (2018): 1023-1032.
Chicago
Chen, J., Lou, Q., He, L., Wen, C., Lin, M., Zhu, Z., Wang, F., Huang, L., Lan, W., Iwamoto, A., Yang, X., Liu, H."Reduced-gliotoxin induces ROS-mediated anoikis in human colorectal cancer cells". International Journal of Oncology 52, no. 3 (2018): 1023-1032. https://doi.org/10.3892/ijo.2018.4264
Copy and paste a formatted citation
x
Spandidos Publications style
Chen J, Lou Q, He L, Wen C, Lin M, Zhu Z, Wang F, Huang L, Lan W, Iwamoto A, Iwamoto A, et al: Reduced-gliotoxin induces ROS-mediated anoikis in human colorectal cancer cells. Int J Oncol 52: 1023-1032, 2018.
APA
Chen, J., Lou, Q., He, L., Wen, C., Lin, M., Zhu, Z. ... Liu, H. (2018). Reduced-gliotoxin induces ROS-mediated anoikis in human colorectal cancer cells. International Journal of Oncology, 52, 1023-1032. https://doi.org/10.3892/ijo.2018.4264
MLA
Chen, J., Lou, Q., He, L., Wen, C., Lin, M., Zhu, Z., Wang, F., Huang, L., Lan, W., Iwamoto, A., Yang, X., Liu, H."Reduced-gliotoxin induces ROS-mediated anoikis in human colorectal cancer cells". International Journal of Oncology 52.3 (2018): 1023-1032.
Chicago
Chen, J., Lou, Q., He, L., Wen, C., Lin, M., Zhu, Z., Wang, F., Huang, L., Lan, W., Iwamoto, A., Yang, X., Liu, H."Reduced-gliotoxin induces ROS-mediated anoikis in human colorectal cancer cells". International Journal of Oncology 52, no. 3 (2018): 1023-1032. https://doi.org/10.3892/ijo.2018.4264
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team